Post by sportsrancho on Nov 11, 2015 8:41:35 GMT -5
Plead? How do you get that interpretation from Hakan's comment:
"As I mentioned last quarter, we were pleased to welcome the new Chief Medical Officer leading the development team. And in the last couple of months, our development group has been very busy moving ahead with the formulation work on the pulmonary hypertension program, as well as lining up a dozen more product candidates with commercial potential. And there is no way we can fund all of this potential activity, so we have also initiated discussions with several firms that could participate in product development as strategic or financial partners.
"I have made it clear that I'm open to any creative approach that will give us as many of these programs as possibly funded, and get our technology into the hands of healthcare providers and their patients. So to the participants listening to this call, who have an interest in sharing the risk and the rewards of our product development effort or who have a formulation or drug delivery challenge that our technology may address, I would say this, let's talk. My ambition is to have a robust portfolio of product candidates in the pipeline by this time next year."
---
It amazes me how the same shareholders who complain that Hakan is not using his leadership role, to promote MannKind, then turn around and criticize when he does. "...let's talk" is an invitation, not a plea. Hakan did exactly the right thing in promoting TS potential, and I hope that Hakan will soon start bringing Dr. Urbanski to speak at these conferences.
---
Finally - and the silence speaks VOLUMES here - where is mention of the pain med? I'm very confident at this point that we have a partner for a TS pain API and Hakan is restrained from even mentioning it by a confidentiality agreement. The pain pipeline is too big for Hakan to have ignored it like this. I'm speculating about a new partner, of course, but I'm going to put my money on it and start loading up. What did Hakan say about this? Here's his response to Jay Olson:
Jay Olson
"Okay. And then, just on the pipeline, I appreciate the color there on the progress; can you tell us how close you are to moving any of your pipeline assets into the clinic, and when is the soonest that MannKind could sign a partnership or licensing deal to monetize some of those pipeline assets?"
Hakan Edstrom
"Well, in regards to -- I would say they are certainly month away from going into a clinic. I mean, they are in the formulation stage right now, particularly on the pulmonary hypertension. In regards to entering into other development partnership or financial partnership, the only thing I can say that, that actioned [ph] over the last week, we've had discussions with potential partners. However, there are still negotiations to be had. So I would say -- I would hope that we could possibly announce something before the end of the year -- oh, sorry, within the next quarter, but that's as specific as I can be at this point in time."
---
'nuff said.
Let's talk is a invitation, not a plea! Agree! Thought I was crazy till I read this post:-) It didn't sound weak to me at all.